{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:05:27Z","timestamp":1769756727670,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00059-025-05355-5","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:24:10Z","timestamp":1767972250000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ESC-Leitlinien zu Myokarditis und Perikarditis","ESC guidelines on myocarditis and pericarditis"],"prefix":"10.1007","volume":"51","author":[{"given":"Bernhard","family":"Maisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Heidecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette","family":"Schulz-Menger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"7","key":"5355_CR1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ehj.2004.02.002","volume":"25","author":"B Maisch","year":"2004","unstructured":"Maisch\u00a0B, Seferovic\u00a0PM, Ristic\u00a0AD et\u00a0al (2004) ESC-Guidelines on the diagnosis and management of pericardial diseases. Eur Heart\u00a0J 25(7):587\u2013610","journal-title":"Eur Heart J"},{"key":"5355_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf192","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger\u00a0J, Collini\u00a0V, Gr\u00f6schel\u00a0J et\u00a0al (2025) 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf192","journal-title":"Eur Heart J"},{"key":"5355_CR3","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"2015","author":"Y Adler","year":"2015","unstructured":"Adler\u00a0Y, Charron\u00a0P, Imazio\u00a0M et\u00a0al (2015) 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart\u00a0J 2015:2921\u20132964","journal-title":"Eur Heart J"},{"key":"5355_CR4","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"ALP Caforio","year":"2013","unstructured":"Caforio\u00a0ALP, Pankuweit\u00a0S, Arbustini\u00a0E et\u00a0al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a\u00a0position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart\u00a0J 34:2636\u20132648. https:\/\/doi.org\/10.1093\/eurheartj\/eht210","journal-title":"Eur Heart J"},{"key":"5355_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","volume":"85","author":"Writing Committee","year":"2025","unstructured":"Writing Committee, Drazner\u00a0MH, Bozkurt\u00a0B et\u00a0al (2025) 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A\u00a0Report of the American College of Cardiology Solution Set Oversight Committee. J\u00a0Am Coll Cardiol 85:391\u2013431. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.080","journal-title":"J Am Coll Cardiol"},{"key":"5355_CR6","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.jacc.2019.08.1061","volume":"74","author":"GD Aquaro","year":"2019","unstructured":"Aquaro\u00a0GD, Ghebru Habtemicael\u00a0Y, Camastra\u00a0G et\u00a0al (2019) Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis. J\u00a0Am Coll Cardiol 74:2439\u20132448. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1061","journal-title":"J Am Coll Cardiol"},{"key":"5355_CR7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.jacc.2016.02.013","volume":"67","author":"P Lurz","year":"2016","unstructured":"Lurz\u00a0P, Luecke\u00a0C, Eitel\u00a0I et\u00a0al (2016) Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. J\u00a0Am Coll Cardiol 67:1800\u20131811. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.013","journal-title":"J Am Coll Cardiol"},{"key":"5355_CR8","series-title":"Cardiol","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume-title":"Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation","author":"VM Ferreira","year":"2018","unstructured":"Ferreira\u00a0VM, Schulz-Menger\u00a0J, Holmvang\u00a0G et\u00a0al (2018) Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation. Cardiol, Bd 72. Expert, Recommendations. J\u00a0Am Coll, S\u00a03158\u20133176 https:\/\/doi.org\/10.1016\/j.jacc.2018.09.072"},{"key":"5355_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad194","author":"E Arbelo","year":"2023","unstructured":"Arbelo\u00a0E, Protonotarios\u00a0A, Gimeno\u00a0JR et\u00a0al (2023) 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194 (ehad194)","journal-title":"Eur Heart J"},{"key":"5355_CR10","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M et\u00a0al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"5355_CR11","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M et\u00a0al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 43:3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"key":"5355_CR12","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","volume":"30","author":"A Frustaci","year":"2009","unstructured":"Frustaci\u00a0A, Russo\u00a0MA, Chimenti\u00a0C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart\u00a0J 30:1995\u20132002. https:\/\/doi.org\/10.1093\/eurheartj\/ehp249","journal-title":"Eur Heart J"},{"key":"5355_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.acvd.2023.07.004","volume":"116","author":"M Kerneis","year":"2023","unstructured":"Kerneis\u00a0M, Cohen\u00a0F, Combes\u00a0A et\u00a0al (2023) Rationale and design of the ARAMIS trial: Anakinra versus placebo, a\u00a0double blind randomized controlled trial for the treatment of acute myocarditis. Arch Cardiovasc Dis 116:460\u2013466. https:\/\/doi.org\/10.1016\/j.acvd.2023.07.004","journal-title":"Arch Cardiovasc Dis"},{"key":"5355_CR14","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1053\/euhj.2002.3152","volume":"23","author":"B Maisch","year":"2003","unstructured":"Maisch\u00a0B, Ristic\u00a0AD, Pankuweit\u00a0S (2003) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolon. The way to avoid side effects of systemic corticosteroid therapy. Eur Heart\u00a0J 23:1503\u20131508","journal-title":"Eur Heart J"},{"key":"5355_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1053\/euhj.2002.3328","volume":"23","author":"B Maisch","year":"2003","unstructured":"Maisch\u00a0B, Ristic\u00a0AD, Pankuweit\u00a0S, Neubauer\u00a0A, Moll\u00a0R (2003) Neoplastic pericadial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart\u00a0J 23:1625\u20131631","journal-title":"Eur Heart J"},{"key":"5355_CR16","first-page":"135","volume-title":"Intrapericardial Treatment in Pericardial Disease. Interventional Pericardiology","author":"V Maisch","year":"2011","unstructured":"Maisch\u00a0V, Risti\u0107\u00a0AD, Seferovi\u0107\u00a0PM, Tsang\u00a0TSM (2011) Intrapericardial Treatment in Pericardial Disease. Interventional Pericardiology. Springer, Heidelberg, S\u00a0135\u2013153"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05355-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05355-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05355-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:55:52Z","timestamp":1769702152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05355-5"}},"subtitle":["Erste gemeinsame europ\u00e4ische Leitlinie f\u00fcr Myokarditis und Perikarditis","First combined European guidelines for myocarditis and pericarditis"],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5355"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05355-5","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"1 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Maisch, J.\u00a0Gr\u00f6schel, B.\u00a0Heidecker und J.\u00a0Schulz-Menger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}